187 related articles for article (PubMed ID: 35908329)
21. Vasopressin compared with norepinephrine augments the decline of plasma cytokine levels in septic shock.
Russell JA; Fjell C; Hsu JL; Lee T; Boyd J; Thair S; Singer J; Patterson AJ; Walley KR
Am J Respir Crit Care Med; 2013 Aug; 188(3):356-64. PubMed ID: 23796235
[TBL] [Abstract][Full Text] [Related]
22. THE EFFICACY AND SAFETY OF VASOPRESSORS FOR SEPTIC SHOCK PATIENTS: A SYSTEMIC REVIEW AND NETWORK META-ANALYSIS.
Jia L; Wang P; Li C; Xie J
Shock; 2023 Dec; 60(6):746-752. PubMed ID: 37548686
[TBL] [Abstract][Full Text] [Related]
23. Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials.
Vasu TS; Cavallazzi R; Hirani A; Kaplan G; Leiby B; Marik PE
J Intensive Care Med; 2012; 27(3):172-8. PubMed ID: 21436167
[TBL] [Abstract][Full Text] [Related]
24. Association Between US Norepinephrine Shortage and Mortality Among Patients With Septic Shock.
Vail E; Gershengorn HB; Hua M; Walkey AJ; Rubenfeld G; Wunsch H
JAMA; 2017 Apr; 317(14):1433-1442. PubMed ID: 28322415
[TBL] [Abstract][Full Text] [Related]
25. Vasoactive drugs for vasodilatory shock in ICU.
Holmes CL; Walley KR
Curr Opin Crit Care; 2009 Oct; 15(5):398-402. PubMed ID: 19542884
[TBL] [Abstract][Full Text] [Related]
26. Hydrocortisone versus vasopressin for the management of adult patients with septic shock refractory to norepinephrine: A multicenter retrospective study.
Kulesza S; Gignac L; Colvin CA; Boll S; Giuliano C; Haan B; Allen B; Perez MM; Allen M; Edwin SB
Pharmacotherapy; 2023 Aug; 43(8):787-794. PubMed ID: 37148191
[TBL] [Abstract][Full Text] [Related]
27. Analysis of Mortality in Patients Treated With Phenylephrine in Septic Shock.
Patel VV; Sullivan JB; Cavanaugh J
J Pharm Pract; 2023 Feb; 36(1):15-18. PubMed ID: 33752492
[TBL] [Abstract][Full Text] [Related]
28. The cardiopulmonary effects of vasopressin compared with norepinephrine in septic shock.
Gordon AC; Wang N; Walley KR; Ashby D; Russell JA
Chest; 2012 Sep; 142(3):593-605. PubMed ID: 22518026
[TBL] [Abstract][Full Text] [Related]
29. The effect of early vasopressin use on patients with septic shock: A systematic review and meta-analysis.
Huang H; Wu C; Shen Q; Xu H; Fang Y; Mao W
Am J Emerg Med; 2021 Oct; 48():203-208. PubMed ID: 33975132
[TBL] [Abstract][Full Text] [Related]
30. Vasopressin vs noradrenaline: Have we found the perfect recipe to improve outcome in septic shock?
Chidambaram S; Goh EL; Rey VG; Khan MA
J Crit Care; 2019 Feb; 49():99-104. PubMed ID: 30415181
[TBL] [Abstract][Full Text] [Related]
31. Influence of Timing and Catecholamine Requirements on Vasopressin Responsiveness in Critically ill Patients with Septic Shock.
Jakowenko ND; Murata J; Kopp BJ; Erstad BL
J Intensive Care Med; 2022 Nov; 37(11):1512-1519. PubMed ID: 35195486
[No Abstract] [Full Text] [Related]
32. Effect of Early Administration of Vasopressin on New-Onset Arrhythmia Development in Patients With Septic Shock: A Retrospective, Observational Cohort Study.
McCloskey MM; Gibson GA; Pope HE; Giacomino BD; Hampton N; Micek ST; Kollef MH; Betthauser KD
Ann Pharmacother; 2024 Jan; 58(1):5-14. PubMed ID: 37056040
[No Abstract] [Full Text] [Related]
33. The role of vasopressin and the vasopressin type V1a receptor agonist selepressin in septic shock.
Saad AF; Maybauer MO
J Crit Care; 2017 Aug; 40():41-45. PubMed ID: 28319910
[TBL] [Abstract][Full Text] [Related]
34. Norepinephrine combined with phenylephrine versus norepinephrine in patients with septic shock: a retrospective cohort study.
He D; Hu H; Hong L; Zhang L; Lu X; Gu WJ; Lyu J; Yin H
BMC Infect Dis; 2023 Apr; 23(1):221. PubMed ID: 37029365
[TBL] [Abstract][Full Text] [Related]
35. Discontinuation of Vasopressin Before Norepinephrine in the Recovery Phase of Septic Shock.
Hammond DA; McCain K; Painter JT; Clem OA; Cullen J; Brotherton AL; Chopra D; Meena N
J Intensive Care Med; 2019 Oct; 34(10):805-810. PubMed ID: 28618919
[TBL] [Abstract][Full Text] [Related]
36. Vasopressin versus norepinephrine infusion in patients with septic shock.
Russell JA; Walley KR; Singer J; Gordon AC; Hébert PC; Cooper DJ; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ; Ayers D;
N Engl J Med; 2008 Feb; 358(9):877-87. PubMed ID: 18305265
[TBL] [Abstract][Full Text] [Related]
37. Association of Catecholamine Dose, Lactate, and Shock Duration at Vasopressin Initiation With Mortality in Patients With Septic Shock.
Sacha GL; Lam SW; Wang L; Duggal A; Reddy AJ; Bauer SR
Crit Care Med; 2022 Apr; 50(4):614-623. PubMed ID: 34582425
[TBL] [Abstract][Full Text] [Related]
38. Vasopressor Discontinuation Order in Septic Shock With Reduced Left Ventricular Function.
Taylor A; Jones T; Forehand CC; Smith SE; Dykes H; Newsome AS
J Pharm Pract; 2022 Dec; 35(6):879-885. PubMed ID: 33977793
[TBL] [Abstract][Full Text] [Related]
39. Optimizing Vasopressin Use and Initiation Timing in Septic Shock: A Narrative Review.
Sacha GL; Bauer SR
Chest; 2023 Nov; 164(5):1216-1227. PubMed ID: 37479058
[TBL] [Abstract][Full Text] [Related]
40. Use of vasopressin in the treatment of refractory septic shock.
Kny KT; Ferreira MAP; Pizzol TDSD
Rev Bras Ter Intensiva; 2018; 30(4):423-428. PubMed ID: 30570030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
